The future of 3D bioprinting in epidemiology looks promising. As the technology continues to advance, it is likely to become an integral tool in disease research, drug development, and public health. Ongoing research and collaboration between scientists, healthcare professionals, and regulatory bodies will be crucial in harnessing the full potential of this technology.
